About

Kayani Biosystems develops modular AI-driven frameworks for the generative design of functional biomolecules, including antimicrobial peptides, enzymes, epitopes, cytokine binders, and senolytics.

Our core infrastructure combines pretrained protein language models, pocket-aware conditioning, structural prediction, and mechanism inference to rapidly identify high-confidence biological candidates optimized for specificity, safety, and performance.

The system supports end-to-end workflows—from raw sequence input to mechanism-labeled, structurally validated 3D complexes. Designed for flexible deployment, our technology accelerates timelines across applied R&D, from emergent therapeutic design to mission-critical biodefense responses.